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Summary 
The interactions between CD40 on B cells and its ligand gp39 on activated T  helper cells are 
known to be essential  for the development of thymus-dependent humoral immunity. How- 
ever, CD40 is also functionally expressed on thymic epithelial cells and dendritic cells, suggest- 
ing that gp39-CD40  interactions may also  play a  role in  thymic education,  the  process by 
which self-reactive cells are deleted from the T  cell repertoire. Six systems of negative selection 
were studied for their reliance on gp39-CD40 interactions to mediate negative selection. In all 
cases, when the antigen/superantigen was endogenously expressed (in contrast to exogenously 
administered), negative selection was blocked by loss of gp39 function. Specifically, blockade 
of gp39-CD40 interactions prevented the deletion of thymocytes expressing V[33, V[311,  and 
V[312, specificities normally deleted in BALB/c mice because of the endogenous expression of 
minor lymphocyte-stimulating determinants.  Independent verification of a  role  of gp39  in 
negative selection was provided by studies in gp39-deficient mice where alterations in T  cell 
receptor (TCP,) V[3 expression were also observed. Studies were also performed in the AND 
TCR. transgenic (Tg) mice, which bear the Vti11,V[33 TCR. and recognize both pigeon cyto- 
chrome c (PCC)/IE  k and H-2A  s. Neonatal administration ofanti-gp39 to AND TCP, Tg mice 
that  endogenously express H-2A  s or endogenously produce PCC  prevented the  deletion of 
TCR Tg T  cells.  In contrast, deletion mediated by high-dose PCC peptide antigen (adminis- 
tered exogenously) in AND TCI< mice was unaltered by administration ofanti-gp39. In addi- 
tion, deletion by Staphylococcus enterotoxin B in conventional mice was also unaffected by anti- 
gp39 administration, gp39 expression was induced on thymocytes by mitogens or by antigen 
on TCR Tg thymocytes. Immunohistochemical analysis of B7-2 expression in the thymus in- 
dicated that,  in  the  absence of gp39,  B7-2  expression was  substantially reduced.  Taken to- 
gether, these data suggest that gp39 may influence negative selection through the regulation of 
costimulatory molecule expression. Moreover, the data support the hypothesis that, for nega- 
tive selection to some endogenously produced antigens, negative selection may be dependent 
on TCR. engagement and costimulation. 
A 
lthough it is clear that both positive and negative selec- 
tion  in  the  thymus  require  recognition  of peptide- 
MHC  complexes by the TCP,,  the requirement for addi- 
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tional costimulatory molecules is unclear. This is in contrast 
to the activation of  peripheral T cells, where it has repeated- 
ly been demonstrated that recognition ofpeptide-MHC by 
TCIK on mature peripheral T  cells is insufficient for optimal 
T cell activation and that costimulatory molecules provided by 
APCs are necessary to achieve complete T cell activation (1). 
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are sufficient to induce deletion ofthymocytes (2),  two re- 
ports  suggest  that  additional  costimulatory  signals  are  re- 
quired  (3,  4).  Double-positive  thymocytes  express  CD2, 
CD5,  lymphocyte-function-associated antigen  1  (LFA-1), 
very late  antigen  4  (VLA-4),  and  CD28,  suggesting  that 
any of these molecules could potentially be involved in in- 
teractions with  thymic APC that mediate  the processes of 
thymic selection (3).  The requirement for CD28-B7 inter- 
actions in thymic selection has been examined in a number 
of distinct models. A causal role for B7 in negative selection 
is  suggested  by recent  studies  demonstrating  that  the  ex- 
pression  of B7  within  the  thymus  medullary  epithelium 
was T  dependent and correlated with epithelium-mediated 
deletion  of V[35 +  thymocytes (5).  However,  other studies 
using in vitro or in vivo models of negative selection have 
provided conflicting results as to the requirement for B7 in 
negative selection  (3-8).  Thus,  a clear role for the CD28/ 
B7  signaling  pathway  in  thymic  selection  has  yet  to  be 
demonstrated. 
Although the respective roles of a number of costimula- 
tory  molecules  in  thymic  selection  have  been  examined, 
the  role  of gp39-CD40  interactions  remains  unknown. 
The fact that CD40 is functionally expressed  on epithelial 
ceils  (9)  of the thymus as well as on other APCs (10)  indi- 
cates  that  it  may  participate  in  thymic  selection.  The 
present study examines the role ofgp39-CD40 interactions 
in a number of distinct  models of negative  selection.  The 
results demonstrate that,  in some models of negative selec- 
tion, lack of gp39 function permits the escape of self-reac- 
tive  T  cells.  Furthermore,  gp39 expression was critical for 
the medullary expression orB7-2 within the thymus. Since 
B7-2  expression  in  the  thymus  is  gp39  dependent,  gp39 
may impart its  effects on negative selection by its  capacity 
to  regulate  the  expression  of costimulatory  molecules  on 
thymic  epithelium  or  thymic  dendritic  cells.  These  data 
suggest that gp39 plays an active role in shaping the T  cell 
repertoire,  most likely through signaling of CD40-bearing 
thymic APCs. 
Materials  and Methods 
Mice.  BALB/c mice were bred in the Animal Resource Fa- 
cility at Dartmouth Medical School (Lebanon, NH)  using adult 
breeding pairs obtained from The Jackson Laboratory (Bar Har- 
bor, ME).  (CBA/J  ￿  gp39 deficient)F 1 mice were obtained by 
mating  CBA/J  (H-2  k/k) adult  males  (The Jackson  Laboratory) 
with  gp39-deficient  (H-2  b/u) homozygous (-/-)  females.  Be- 
cause the gp39 gene is encoded on the X  chromosome, female 
progeny  of this  mating  were  H-2  b/k  heterozygous  (+/-)  for 
gp39, whereas male F 1 progeny were H-2  u/k gp39 deficient  (-/0). 
H-2  k/k AND 1 TCR transgenic  (Tg) were bred and maintained at 
Dartmouth Medical  School.  H-2  ~/k AND TCR Tg mice were 
1Abbreviations used in this paper: CsA, cyclosporine  A; DN, double nega- 
tive; DP, double positive; HIg, hamster Ig; PCC, pigeon cytochrome c; 
PCCF, pigeon cytochrome c peptide fragment; RT, room temperature; 
SEB, Staphylococcus enterotoxin B; SP, single positive; Tg, transgenic; wt, 
wild type. 
generated  by  mating  adult  male  H-2  k/k  AND  TCR  Tg  with 
B10.S  (H-2  ~/S) females. IkO pigeon cytochrome c (PCC) Tg mice 
(designated  PCC  Tg)  were  generated  as described  (Oehen,  S., 
and S. M. Hedrick, manuscript in preparation).  These mice were 
generated using a construct consisting  of PCC fused to the influ- 
enza neuraminidase  signal anchor driven by the H-2K  b promoter 
and Ig hea  W  chain enhancer. PCC expression  was detectable  in 
the spleen  and thymus by Northern analysis. (AND TCR Tg X 
PCC  Tg)F  1 mice were  obtained by mating homozygous AND 
TCR  Tg  (H-2  b/b)  and  heterozygous  PCC  Tg  (H-2  a/a)  adult 
breeding  pairs.  This  mating  generated  H-2  b/a  progeny  that 
expressed  the AND TCR Tg, half of which also expressed  the 
PCC Tg. 
Antibodies and Reagents.  The following mAbs,  obtained from 
Pharmingen (San Diego, CA), were used in this study: RM4-4, 
anti-murine  CD4;  53-6.72,  anti-murine  CD8;  RR8-1,  anti- 
murine  Vot11;  KJ-25,  a  hamster  anti-murine  V[33; MR9-4,  a 
mouse  anti-murine  V[35.1, V[35.2;  RR47,  anti-murine  VJ36; 
TR310,  anti-murine  V137; biotin-MR10-2,  anti-murine  VI39; 
RR3-15 anti-murine  VI311; MR11-1,  anti-murine  V[312; and 
GL1,  anti-murine  B7-2.  16-10A1,  hamster  anti-murine  B7-1, 
was kindly provided by Hans Reiser (Dana-Farber Cancer Insti- 
tute,  Boston,  MA).  F23.1,  anti-murine  VI38.1, 8.2  (11) and 
MR1,  anti-murine  gp39  (12), were  purified  by DEAE  HPLC 
from  ascites fluid.  Purified,  conjugated  rat  IgG  or  hamster  Ig 
(HIg) were used as isotype controls in the flow cytometric assays. 
Control HIg was similarly purified from normal hamster serum. 
PCC peptide fragment (PCCF) corresponding to residues 88-104 
of PCC  (KAERADLIAYLKQATAK) was  synthesized  in  the 
Peptide Synthesis Core Facility, Department of Pathology, Dart- 
mouth Medical School. 
Anti-gp39  Treatment.  BALB/c,  H-2  ~/k AND  TCR  Tg,  and 
(AND TCR Tg X PCC Tg)FI were treated every 2 d from birth 
with purified Hlg or anti-gp39 (MR1;  100 Ixg/injection).  Adult 
mice were treated with 250 Ixg/injection. 
Flow Cytometric Analysis.  Before staining, single-cell suspensions 
were  prepared  and spun  through  Ficoll-Hypaque,  followed by 
washing in balanced salts solution.  Thymocytes (0.5  ￿  106) were 
stained by incubation with primary antibodies  for 30 min at 4~ 
Rat serum and 25 Ixg of the anti-Fc'y1klI  antibody 2.4G2 were 
added to eliminate  background staining.  Cells were then washed 
with  staining  buffer  and  subsequently  incubated  with  the  PE- 
streptavidin  for 30 min at 4~  After a second wash,  the samples 
were fixed  in  1.25￿  PBS,  1% formaldehyde and analyzed  on a 
flow cytometer (FACS  |  440;  Becton Dickinson &  Co.,  Cock- 
eysville,  MD).  A  minimum  of 10,000  cells were  collected for 
each sample. Two-color contours are represented as 5% probabil- 
it,/plots. 
Antigen-induced  Proliferation of T  Cells.  CD4 + T  cells were ob- 
tained  from thymus by complement-mediated  lysis. Cells  from 
control or anti-gp39-treated  H-2  b/s AND TCR Tg mice were 
stimulated  with  variable  concentrations  of moth  cytochrome c 
(cross-reactive  antigen)  in  the  presence  of APCs and  were  as- 
sessed for proliferation by [3H]thymidine  incorporation after 48 h 
as described  (13). 
Staphylococcus  Enterotoxin  B  (SEB)-mediated  Deletion  of  Thy- 
mocytes.  SEB  (20 /~g/d)  was administered  three  times  weekly to 
BALB/c mice from birth. In addition,  mice were similarly treated 
with  control  HIg  or  anti-gp39  (100  /*g/d).  Deletion  of thy- 
mocytes was assessed flow cytometrically by staining  with  anti- 
CD4, -CD8, and -V/38. 
Antigen/Mitogen-induced Expression of  gp39 on Thymocytes.  Thy- 
mocytes (5  X  106/ml)  from AND TCR Tg (for PCCF-induced 
1378  An Essential Role for gp39, the Ligand for CD40, in Thymic Selection expression) or BALB/c mice  (for mitogen-induced expression) 
were cultured for 12 h in the presence or absence of PCCF, Con 
A (5 I~g/ml), or PMA (10 ng/ml) and ionomycin (250 nM) to 
induce  gp39. Expression of gp39 was detected  flow cytometri- 
cally by staining with a combination  of CD4-PE, CD8-Cy, and 
biotin anti-gp39. 
Immunohistochemical Analysis of B7-2 Expression in  Thymus. 
Fresh thymuses from 21-d-old wild-type  (wt) or gp39-deficient 
mice were snap frozen in liquid nitrogen, and 8-/zm cryostat sec- 
tions were cut. Sections were stored at room temperature  (RT) 
overnight  under humidified conditions. After 1 h of air drying, 
sections were fixed in fresh acetone  for 10 man and incubated 
overnight  with a biotinylated  rat anti-murine B7-2  (Pharmin- 
gen). Sections were rinsed three times with PBS and incubated 
for 1 h at RT with a biotinylated  rabbit anti-rat IgG  (H  +  L 
chain)  (Vector  Laboratories,  Inc.,  Burlingame,  CA). Sections 
were washed and incubated  for 1 h at RT with PE-conjugated 
streptavidin (Southern Biotechnology Associates, Inc., Birming- 
ham, AL). Stained sections were scanned for fluorescence using a 
laser cytometer (ACAS Ultima; Meridian Instruments, Inc., Oke- 
mos, MI). The digital image created by laser scanning was further 
analyzed to quantitate the average fluorescence intensity of each 
section. The medullary region was gated for each section and an- 
alyzed to determine an average fluorescence intensity. 
Results 
gp-39-dependent Mls-mediated Selection in BALB/c Mice. 
To examine if gp39-CD40 interactions were critical in the 
development  of mature  T  and/or  B  cells,  mice  were 
treated from birth  with  anti-gp39  or HIg,  and  T  and  B 
subsets  were  examined. As  anticipated from the lympho- 
cyte subset analysis  from gp39- and CD40-deficient mice 
(14,  15) as well as hyper-IgM patients (16), no alterations in 
thymocyte, mature  T  cell,  or mature B  cell subsets  were 
noted in mice chronically treated with anti-gp39 (data  not 
shown).  To  determine  if gp39-CD40  interactions  influ- 
enced thymic selection, the deletion of T  cells to a variety 
of antigens in both TCR Tg and non-Tg models of nega- 
tive selection was investigated. 
The deletion ofT cells expressing TCRs reactive against 
endogenous retroviral Mls antigens was examined in mice 
chronically treated with anti-gp39.  Due to the  expression 
of Mls determinants encoded by endogenous mouse mam- 
mary tumor viruses, young adult BALB/c mice normally 
delete TCR  expressing V~3,  V[311,  and  V~12,  but  not 
TCR using V[38 family members (17).  Mice treated from 
birth with anti-gp39 or HIg were analyzed for the presence 
ofT cells expressing V[33, V[~11, V[312, and V~8 TCR. T 
cell subset analysis was performed by correlated flow cyto- 
metric analysis of CD4, CD8, and TCR usage at 4-6 wk of 
age.  Thymocytes expressing V~3,  V~11,  and V[312  were 
absent in the CD4+CD8 -  or CD4-CD8 + single-positive 
(SP) thymocyte populations obtained from normal, untreated 
(data  not  shown)  or  control HIg-treated  BALB/c  mice, 
whereas the V~8 population was present (Fig. 1, left). How- 
ever, analysis  of V[33, V[311,  and VI312  expression on SP 
thymocytes from animals  treated  in  vivo with  anti-gp39 
demonstrated increases in the percentage of SP CD4 + or 
CD8 + cells expressing V[311 + (three- to fivefold) or V~12 + 
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(16--20-fold), although only modest increases in V[33-ex- 
pressing thymocytes were observed (Fig.  1, right). The per- 
centage  of V133-, V1311-,  and  VIM2-expressing  SP  thy- 
mocytes in mice treated with anti-gp39 was similar to that 
in  a nondeleting strain,  C57BL/6  (18)  (data not shown). 
V[33-,  V[311-,  and  V[312-bearing  thymocytes were  de- 
tected primarily in the CD4 and CD8 SP subsets  and were 
not present in the double-positive (DP) or double-negative 
(DN)  thymocyte populations.  These results  demonstrated 
that  Mls-mediated  clonal deletion of self-reactive T  cells 
was prevented as a result of anti-gp39 treatment. 
Altered Mls-mediated Selection in gp39-de~ent Mice.  To fur- 
ther confirm the participation of gp39 in Mls-mediated se- 
lection of thymocytes, analysis of TCR V~ usage in gp39- 
deficient  mice  was  performed.  Normal  CBA/J  mice 
(Mls a,c,f) (data  not shown)  and gp39  heterozygous CBA/J 
F 1 mice delete a host ofV[3-bearing T  cells, including V~3, 
V~5,  V~6,  V[37, V139, V~11,  and V[312  (Fig.  2).  How- 
ever, in CBA/J F 1 mice genetically deficient in gp39, there 
was an increase in CD4 and/or CD8 SP thymocytes bear- 
ing V[35, V[36, V~7, V[311, and V[312 TCRs with modest 
or no changes in the other VJ3-expressing thymocyte pop- 
ulations.  These results confirm those obtained from mice 
chronically treated with anti-gp39 and provide supportive 
evidence for the role of gp39 in Mls-mediated deletion of 
thymocytes. 
gp39-dependent Selection by H-2A  s in the AND  TCR Tg 
Mice.  To evaluate the role of gp39-CD40 interactions in 
the selection ofT cells to other self antigens, a third in vivo 
system  of negative  selection  involving  TCR  Tg  mice 
(AND TCR Tg) expressing an 0t/f3 TCR specific for pi- 
geon or moth cytochrome c in association with H-2E  k class 
II MHC molecules was used (19).  Thymocytes from these 
mice undergo efficient maturation in the presence of H-2Ek; 
however, in the presence of H-2A  s, the vast majority of Tg 
thymocytes undergo negative selection (13).  Negative se- 
lection mediated by H-2A  s results  in the deletion of late- 
stage  CD4/CD8  DP  thymocytes, leading to a virtual ab- 
sence of TCR Tg CD4 +  SP thymocytes (13).  To deter- 
mine whether gp39-CD40 interactions play a role in this 
in vivo model of negative selection, H-2  ~/k AND TCR Tg 
mice  were  treated  in  vivo with  anti-gp39  or  control  Ig 
from birth. Analysis of thymocytes from untreated or HIg- 
treated mice revealed a large percentage of DP  (40%) and 
DN  (43%)  immature thymocytes and an almost complete 
absence of CD4 SP (9%) thymocytes, indicating that nega- 
tive selection of thymocytes bearing the Tg TCR had oc- 
curred in  these  mice  (Fig.  3,  top). The majority of thy- 
mocytes in these mice expressed low to moderate levels of 
the VoU 1 and V~3 TCR  transgene components,  charac- 
teristic of the DP  population  (data  not shown).  Negative 
selection of a large number of thymocytes in H-2  ~/k mice 
was also reflected by a 50-65% decrease in the total num- 
ber of thymocytes as well as in the total number of mature 
CD4  SP  thymocytes (Table  1).  In  contrast,  H-2  S/k mice 
treated with anti-gp39  contained a large number of CD4 
SP thymocytes (26%;  Fig.  3,  bottom) and fewer immature 
DN  cells  (24%).  Although  the  levels  of CD4  SP  thy- mocytes observed in normal H-2  wk Tg mice are generally 
higher (60-70%;  see Fig. 4) than those seen in H-2  ~/k mice 
treated with anti-gp39, blockade of gp39 function does re- 
sult in a  dramatic increase in both  the percentage and the 
total  number  of  CD4  SP  thymocytes  compared  with 
untreated  or  Hlg-treated  H-2  ~/k  mice.  The  heightened 
levels of V[33 hi  (data  not  shown)  and  Vc~11 hi  thymocytes 
representing the  CD4  SP population in anti-gp39-treated 
mice are also indicative of an absence of negative selection, 
as are the relatively higher numbers  of total and  CD4  SP 
thymocytes (Table 1).  Collectively, these data demonstrate 
that blockade ofgp39-CD40 interactions in the thymus in- 
terferes  with  this  alloantigen-mediated model  of negative 
selection. 
gp39-dependent  Selection by Endogenous PCC Antigen in the 
AND TCR Tg Mice.  The generation of Tg mice endoge- 
nously expressing PCC in the thymus provides a system in 
which to examine the selection ofTg thymocytes to an en- 
dogenously encoded "self antigen/" Mating the AND TCR 
Tg mice with Tg mice expressing PCC  results in the rec- 
ognition  of PCC  self antigen  by thymocytes bearing the 
TCR  specific for PCC  and  results in  their deletion  (Oe- 
hen, S., and S. M. Hedrick, manuscript in preparation). To 
determine whether  gp39  was  required for the deletion of 
mature Tg thymocytes in this model of negative selection, 
AND  TCR  Tg  or  (AND  TCk  Tg  ￿  PCC  Tg)Fj  mice 
were treated from birth with anti-gp39, and the thymocyte 
populations were  examined 4  wk later.  The  results, sum- 
marized in Table 2,  demonstrate a  dramatic decrease (55- 
65%)  in  the  percentage  of CD4 +  Vodl hi  thymocytes and 
an  even  greater decrease (56-83%)  in the  total number of 
mature  CD4 +  Vo~11  hi  thymocytes in  (AND  TCR  Tg  ￿ 
PCC Tg)F  1 mice compared with AND TCR  Tg. The ad- 
ministration of anti-gp39 completely restores the  CD4  SP 
thymocyte compartment  in the  (AND  TCR  Tg  ￿  PCC 
Tg)F~ mice, as can be seen by the increase in both the total 
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Figure 1.  Anti-gp39 treatment prevents Mlsc.Cmediated  deletion ofthymocytes in BALB/c mice. Mice were treated every 2 d from birth with purified 
HIg or anti-gp39 (100 t~g/injection). 4~ wk later, the thymus was removed and stained with a combination of PE anti-CD4, cyanine anti-CD8, and 
FITC-conjugated anti-TCR_ V~3 mAbs  V]3.81, 8.2, V[33, VI311, or VI312. Purified rat IgG was used as an isotype control. The contour plots were first 
gated on the CD8- or CD4- T cell populations (to eliminate DPs), and then represented as CD4 + or CD8 § in combination with V[33, V~8, V~I 1, or 
V~12. Numbers in the upper right comers represent the percentages ofV~ + cells  in the CD4 § or CD8 + thymocyte subsets. A single animal from one of 
four representative experiments is shown for each treatment group. 
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Figure  2.  Mls-mediated deletion of thymocytes is impaired in gp39- 
deficient  mice.  Thymocytes  from  4-6-wk-old  (CBA/J  X  gp39  deft- 
cient)F  1 heterozygous wt (open drcles) or gp39-deficient (dosed cirdes) mice 
(three mice per group) were stained as described in Materials and Meth- 
ods with FITC-conjugated anfi-murine CD4, Cy-chrome-labeled anti- 
murine CD8, and one of the following biotin-conjugated anti-TCR V[3 
mAbs followed by PE-streptavidin: V133, VI35.1, V135.2, V~6, VI37, VI39, 
V[311,  or VI312.  Background staining using a biotin-conjugated isotype 
control mAb is also shown for each subset. A  minimum of 20,000  cells 
were collected for each sample. Data are expressed as the percentage of 
CD4 +, CD8 +, or DP thymocytes beating each particular VI3 TCR.  One 
of three representative experiments is shown. 
number  and  percentage  of CD4 +  V0~11  hi  thymocytes in 
mice receiving anti-gp39 from birth. These results demon- 
strate that blockade of gp39 function interferes with anti- 
gen-mediated deletion of thymocytes in this Tg model of 
negative selection, and provide further support for the hy- 
pothesis that gp39-CD40 interactions play an essential  role 
in negative selection of self-reactive thymocytes. 
gp39-independent  Selection by Peptide Antigen in the AND 
TCR Tg Mice.  Deletion of  antigen-reactive, immature thy- 
mocytes in TCR Tg mice has also been described as a re- 
sult of injection of high doses of soluble, relevant peptide 
(20).  DP thymocytes from AND  TCR Tg mice undergo 
apoptosis  after  administration  of  high-dose,  exogenous 
PCCF (Oehen, S., and S. M. Hedrick, unpublished obser- 
vations). To determine whether administration ofanti-gp39 
interfered with high-dose PCCF-mediated deletion of thy- 
mocytes, AND  TCR Tg mice were injected with PCCF 
(200 p,g three times) or PBS, with or without coadminis- 
tration of anti-gp39.  The total number of thymocytes and 
DP  thymocytes recovered was  assessed 24  h  after the last 
administration  of peptide.  The  results,  shown  in  Fig.  4, 
demonstrate  that,  although  administration  of PCCF  re- 
sulted  in  profound loss  of DP  thymocytes (1.1%  DP  in 
mice receiving PCCF  compared with  19.9% DP in mice 
receiving PBS; Fig.  4, left panels), coadministration of anti- 
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Figure  3.  Anti-gp39 treatment prevents H-2AS-mediated negative se- 
lection of thymocytes in AND  TCR  Tg mice. H-2  s/k AND  TCR  Tg 
mice were treated from birth with either control HIg (top)  or anti-gp39 
(bottom)  antibody as described in Materials and Methods. Thymocytes ob- 
tained  from  4-wk-old  mice  were  double  stained for  CD4  and  CD8. 
Numbers indicate percent thymocytes in each quadrant. 
gp39 did not prevent this deletion (Fig. 4, lower right). It is 
also  noteworthy that  the  prominent  effect of exogenous 
PCCF is the loss of DP thymocytes, whereas endogenous 
production  of PCC  leads  to  loss  of the  SP  CD4  §  thy- 
mocytes. Mice receiving anti-gp39 alone had levels of DP 
thymocytes similar to those of mice receiving PBS (Fig. 4, 
upper right). These results  demonstrate that deletion of DP 
TCR  Tg  thymocytes by  high  concentrations of antigen 
does not appear to be dependent upon gp39,  as DP thy- 
mocytes were not "rescued" by blockade ofgp39 function. 
gp39-independent Selection to SEB.  Deletion of thymocytes 
by exogenous superantigens has also been used extensively 
as a model for negative selection in the thymus. The gp39 
dependency of negative selection mediated by exogenous 
superantigens was also investigated. Administration of SEB 
to neonatal BALB/c mice causes the selective loss of V[38- 
bearing T  cells. To determine whether gp39 was required 
for  deletion  of thymocytes  mediated  by  SEB,  neonatal 
BALB/c mice were administered SEB alone or in combi- 
nation with HIg or anti-gp39 from birth. Administration of 
SEB caused a dramatic loss in the percentage ofVI38-bear  - 
ing T cells in the CD4 (73-82% decrease) and CD8 (53-83% 
decrease)  SP  thymocyte compartments  (Table  3).  Coad- 
ministration of SEB and anti-gp39 did not alter selection of 
V[58-bearing T  cells  (Table 3),  but did result in selective 
survival of V[311- and V[312-bearing SP thymocytes (data 
1381  Foy et al. Table 1.  Anti-gp39 Treatment Partially Blocks Negative  Selection in H-2  '/k AND  TCR Tg Mice and Results in an Increase of CD4 + 
Vee l I hi Mature Thymocytes 
In vivo  Total Vod l h~ 
anti-gp39  Total  Total CD4 +  % Vod 1hi  CD4 + 
treatment*  thymocytes  % CD4 +  thymocytes  CD4 +  thymocytes 
￿  106  ￿  106  ￿  10  r 
-  66.4*  9.2 w  6.1  7.1 w  4.7 
-  63.2  9.0  5.7  5.2  3.3 
+  131.8  25.5  33.6  19.1  29.8 
+  131.8  24.9  32.8  18.9  30.4 
*H-2  s/k AND TCR Tg F1 mice were treated from birth with HIg or anti-gp39. 
*At 4 wk of age the total number of thymocytes recovered from each animal was determined. 
w  Flow cytometric analysis  was performed to determine the number of mature thymocytes. Values represent the percentage of total thymocytes which 
are CD4 + or CD4+Vot11  hi. One of six representative experiments is shown. 
not shown), suggesting that SEB-mediated deletion occurs 
independently of gp39. 
The Response of T  Cells Rescued from Deletion.  To deter- 
mine if anti-gp39 administration altered the functional ca- 
pacity of the rescued T  ceils,  the proliferative response of 
rescued T  cells was tested. Unfortunately, it was not possi- 
ble  to  measure the  proliferative response  of the  BALB/c 
mice to  MIs  c'f nor  the AND TCR  Tg mice to  H-2A  s.  In 
both of these cases,  it has been shown that the response of 
mature T  ceils to Mls  c,f (21)  and H-2A  s (13)  is  extremely 
weak  and poorly detectable.  In spite  of these  limitations, 
the proliferative response to Ag of AND TCR. Tg T  cells 
tolerized  or  rescued  in the  H-2A  s system was  measured. 
CD4 + cells from AND TCR. Tg, H-2  ~/k F, mice that were 
treated with or without anti-gp39 were stimulated in vitro 
with varying concentrations of MCC  presented by APCs 
from H-2k/k--bearing mice.  Measurement of MCC  prolif- 
erative  responses  (Fig.  5)  demonstrated  that  CD4  +  thy- 
mocytes from  anti-gp39-treated mice were  reactive with 
antigen, as demonstrated by proliferative responses two to 
threefold  higher than  those  observed with  CD4  +  T  ceils 
from control mice that have undergone negative selection. 
Similar  results  were  obtained using  CD4  +  T  cells  from 
spleen and lymph node (data not shown). The finding that 
CD4 + T  ceils from control-treated H-2  s/k mice are some- 
what responsive to stimulation with cytochrome c is consis- 
tent with previous reports  demonstrating that  deletion of 
Tg T  ceils, although profound, is not complete (13). These 
results indicate that the blockade of negative selection al- 
lows for the accumulation of increased numbers of mature, 
self-reactive thymocytes in this model system. Similar stud- 
ies performed in the  (AND TCR  Tg X  PCC Tg)F1 mice 
revealed that  mature  thymocytes that  were  rescued  from 
deletion as a result of anti-gp39 treatment mounted strong 
proliferative responses to Ag in vitro, yet mature Tg T  cells 
were not visible in the spleen, indicating that some mecha- 
Table 2.  Anti-gp39 Treatment  Prevents the Deletion  of Mature CD4 + Vee 11  h; Tg Thymocytes  in (AND TCR Tg ￿  PCC Tg)F  1 Mice 
In vivo  Total No. 
anti-gp39  % CD4 +  CD4 + 
Strain*  treatment*  god 1  hi  V(xl 1  hi  % DP  Total No. DP 
￿  106  ￿  106 
AND TCR Tg  -  49-51 ,~  16.3-20.0  34-37  11.2-14.4 
AND TCR. Tg  +  38--44  13.7-15.4  26-47  10.5-15.9 
(AND TCtL Tg 
￿  PCC Tg)F1  -  18-22  3.5-5.9  26-60  9.6-16.8 
(AND TCK Tg 
￿  PCC Tg)F1  +  38-45  12.8-18.3  41-45  13.8-17.1 
*AND TCR Tg or (AND TCR Tg ￿  PCC Tg)F  1  mice were treated with PBS or anti-gp39. 
*Mice (three to four per group) were treated from birth with anti-gp39 (100 b~g/injection,  three times weekly) or PBS (100 lxl/injection, three 
times weekly). 
w  d after birth, thymi were removed and stained for CD4, CD8, and V0d 1 expression  as described in Materials and Methods. A summary of 
two experiments is shown. 
1382  An Essential Role for gp39, the Ligand for CD40, in Thymic Selection PBS  (x gp39 
~_~  2' 
0 
0 
63.7  19.9 
￿9  ~  4.3 
1  2  3 
CD8 
4 1  70.1 
3 
0 
1 
16.8 
2.3 
.....  '2  ........ '3  ........ 
C I)8 
PCC 
:l 
77.5  1.1 
CD8 
4 
3 
2 
PCC+a gp39 
80.2 
11..1 
L~m 
1 
..... L --'  .......  ' 
2  3 
CD8 
1.6 
6.3 
Figure  4,  Anti-gp39 treatment  does  not pre- 
vent  PCCF-mediated  negative  sdection  of DP 
thymocytes in AND TCR Tg mice. Adult AND 
TCR Tg mice were administered 200 ~g PCCF 
(bottom panels) or 0.2 PBS (top  panels) daily for 3 d. 
In addition,  mice were either treated  with anti- 
gp39 (250 ~g/d for 3 d; right panels) or PBS (left 
panels). On day 4, thymocytes were obtained  and 
double stained  for CD4 and  CD8.  Injection of 
exogenous  PCCF results in deletion of DP thy- 
mocytes  in  AND  TCR  Tg  mice  (lower left). 
Coadministration  of anti-gp39  with  PCCF  did 
not prevent PCCF-mediated deletion (lower right). 
The  numbers  indicate  percent  positive  thy- 
mocytes in each quadrant. One of three represen- 
tative experiments is shown. 
nism  of peripheral  tolerance  prevented  the  survival  of es- 
caped, PCC-reactive T  cells in these mice (data not shown). 
Antigen-  and  Mitogen-induced  Expression  of gp39  on 
Thymocytes.  The hypothesis  that  gp39 is involved in neg- 
ative selection implies its expression in the thymus￿9 To de- 
termine  whether  gp39  could  be  expressed  on  cells  in  the 
thymus,  thymocytes  from AND  TCR  Tg mice were  cul- 
tured with antigen and analyzed for expression of gp39.  As 
shown in Table 4, thymocytes cultured with medium alone 
did  not  express  gp39.  However,  the  addition  Of antigen 
(200 nM of PCCF) to the cultures resulted in the induction 
of gp39  on  "5%  of thymocytes.  Three-color  analysis  of 
gp39 expression on the various thymocyte subsets indicated 
that the 94% ofgp39 +  cells were contained in the CD4  SP 
population.  Pharmacological  (PMA/ionomycin)  or  mito- 
gen  (Con  A)  activation  of thymocytes  from  normal  mice 
resulted in the induction ofgp39 on 54-75% ofCD3 + thy- 
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Figure 5.  Anti-gp39 treatment  allows for the survival of antigen-reac- 
tive CD4  + T cel/s. CD4  + T cells were obtained from thymus by comple- 
ment-mediated  lysis. Ceils from control or anti-gp39-treated  AND H-2  b/s 
Tg  mice were  stimulated  with  various  concentrations  of moth  cyto- 
chrome c (cross-reactive antigen)  in the presence  of APCs and were as- 
sessed for proliferation  by [3H]thymidine incorporation after 48 h.  Two 
individual animals (represented by squares or circles) were assessed in each 
group.  Open  symbols  represent  anti-gp39-treated  animals and  closed 
symbols represent control-treated  animals. 
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Table 3.  SEB-mediated Deletion of Vfl8 + Thymocytes Is Not 
Blocked by the Administration of Anti-gp3 9 
In vivo  % V138  +w 
anti-gp39 
treatment*  SEB*  CD4 +  CD8 + 
-  -  22.5-24.7  45.0-52.6 
-  +  4.5-6.0  9.0-21.0 
+  +  2.5-5.2  5.0-7.5 
"Mice (three  per group)  were treated with control Hlg or anti-gp39 
(100 pLg/d, three times weekly) for 4 wk. 
*SEB (20 p+g/d) was administered  on alternating  days. 
+Thymocytes  were stained  for CD4,  CD8,  and  V138 as described  in 
Materials  and Methods.  The number of VI38  + cells is expressed  as a 
percentage of each SP subset.  One of three representative  experiments 
is shown. mocytes, indicating that DP thymocytes must also have the 
capacity to express gp39. From these studies,  it is clear that, 
given the  appropriate signals,  gp39  expression can be in- 
duced on both mature and immature thymocytes. 
Expression  of B7-2  in the  Thymus of gp39-deficient  Mice. 
The expression of B7-2 in the thymus has been implicated 
in  influencing the  process of negative  selection,  and  nu- 
merous studies have shown that gp39 regulates the expres- 
sion of B7-2 on B cells (22-24), Therefore, it was of inter- 
est  to  determine  if the  absence  of gp39  in  the  thymus 
would  alter B7-2  expression.  The  results  of quantitative 
immunohistochemical analysis revealed that, in the absence 
of gp39 compared with wt control mice (6 A), the expres- 
sion  of B7-2  in  the  medullary region of the  thymus was 
substantially reduced in both the gp39-deficient mice (Fig. 
6  B) and in mice chronically treated with anti-gp39  (data 
not  shown).  Quantitation  of B7-2  expression  on  gp39- 
deficient (red bars) and wt  (green bars) mice  is  depicted in 
Fig. 6 C. These data show that gp39 expression in the thy- 
mus is critical for B7-2 expression and that the reduced ex- 
pression of B7-2  (or other CD40-regulated costimulatory 
molecules) may contribute to the defects in negative selec- 
tion observed in the absence ofgp39. 
Discussion 
Although early studies of thymic selection suggested that 
engagement of self-reactive TCR was  necessary and suffi- 
cient  for  the  elimination  of both  DP  and  mature  thy- 
mocytes (2), recent studies indicate that factors other than 
the  engagement  of TCR  alone,  including  costimulatory 
molecules (3, 4), the nature of the Ag (25-27), and the tim- 
ing and distribution of Ag (28), may influence negative se- 
lection. The data presented in this study indicate that nega- 
tive  selection  mediated  by  Mls  (in  BALB/c  and  CBA/J 
mice), by H-2A  s (in AND TCR Tg mice), and by endoge- 
nously expressed PCC in AND TCR Tg X PCC Tg mice 
requires the interaction of gp39 with its  receptor, CD40. 
Studies  in  gp39-deficient  mice  demonstrating  that  some 
Mls-specific V[3-bearing T  cells  are  spared from deletion 
provide  supportive  evidence that  gp39  plays  an  essential 
role  in  negative  selection.  In  contrast  to  these  findings, 
negative selection induced by SEB or by high doses of ex- 
ogenously administered antigen (PCCF in the AND TCR 
Tg mice) occurred in the absence of gp39-CD40  interac- 
tions. The data also demonstrate that thymocytes can be in- 
duced to  express gp39,  and the  expression of gp39  is  re- 
quired for the expression of costimulatory molecules (e.g., 
B7-2)  on  cells within  the  thymus.  Taken together,  these 
data are consistent with the hypothesis that gp39-regulated 
expression of costimulatory molecules in the thymus may 
be critical for the negative selection of T  cells to low-dose, 
endogenously  expressed  antigens/superantigens.  Finally, 
the observation that, in some models of negative selection, 
functional blockade or deletion of gp39 results  in the sur- 
vival of DP as well as SP thymocytes, coupled with the ob- 
servation that gp39 expression can be induced on immature 
CD3 +  thymocytes,  suggests  that  gp39-dependent  thy- 
mocyte deletion may not be limited to ceils of the mature 
SP subset. 
Of the six models of negative selection examined, some 
common characteristics exist amongst models that are de- 
pendent on gp39 for deletion. First, in all models where the 
production of the antigen or superantigen was endogenous, 
negative selection was influenced by anti-gp39 administra- 
tion  or by the  absence of gp39  expression.  That is,  anti- 
gp39 blocked the deletion to T  cells reactive to Mls  c,r and 
altered the deletion of AND TCR Tg T  cells in mice en- 
dogenously expressing H-2A  s or PCC. Furthermore, dele- 
tion to Mls in the gp39-deficient X  CBA/J mice was  sig- 
nificantly  skewed.  In  two  models  in  which  exogenous 
antigen or superantigen was  administered (SEB or exoge- 
nous PCCF),  no effect of anti-gp39 on negative selection 
was  observed. Based on these results,  it appears that anti- 
gp39 interferes with antigen/superantigen-driven selection 
when antigen is produced under conditions that approxi- 
mate physiologic conditions. In contrast, supraphysiological 
concentrations of antigen/superantigen  (such as  that  used 
in  the  exogenous PCCF  and  SEB  models)  may override 
the  requirements  for costimulation  and  allow  thymocyte 
deletion  to  occur in  the  absence  of CD40-mediated  co- 
stimulation.  Attempts  were  made  to  evaluate  whether 
negative selection to low doses of PCCF (exogenously ad- 
ministered)  was  gp39  dependent;  however,  the  level  of 
PCCF-induced deletion was too low to provide defnitive 
results  (data not shown). It is possible that deletion of thy- 
mocytes by high doses of PCCF or SEB may be the result 
of nonspecific deletion due to a gp39-independent corti- 
costeroid stress response elicited by administration of exog- 
enous Ag rather than Ag-specific deletion. Finally, it is also 
clear from the  data  that  the  mechanisms  of deletion  in- 
duced by exogenous versus endogenous PCC are different, 
since the  former caused deletion of the  DP,  whereas  the 
latter only caused alterations in the SP population. 
Low affnity/avidity interactions between TCP, and Ag/ 
MHC may be another hallmark for gp39-dependent selec- 
tion. Mature AND TClq, Tg T  cells do not proliferate in 
response to H-2A  ~ (13), and VI33, 11-, and 12-bearing ma- 
ture T  cells proliferate poorly in response to Mls  c,f (29, 30), 
suggesting that the avidity of the TCR for H-2A  ~  or Mls~'r/ 
MHC is weak. Therefore, thymocytes bearing these TCRs 
most likely interact with these antigens/superantigens in a 
low affinity/avidity fashion. As such,  deletion in  the thy- 
mus requires the contribution of CD40-derived signals. Al- 
though  it is  not  clear that  deletion mediated by endoge- 
nously expressed  PCC  in  the  (AND  TCR  Tg  X  PCC 
Tg)F  1 mice is the result of low-affnity TCR-Ag interac- 
tions, the fact that PCC is believed to be expressed at only 
low levels on the cell surface of these Tg mice (Oehen, S., 
and S. M. Hedrick, manuscript in preparation) supports the 
observation that deletion in this  model also requires gp39- 
dependent costimulatory signals.  In contrast, two gp39-in- 
dependent models of selection are mediated by high-affin- 
ity TCR. ligands  (high-dose PCCF and SEB) that elicit ro- 
bust proliferative responses from mature T  cells. 
Much of the data presented in this report were generated 
1384  An Essential Role for gp39, the Ligand for CD40, in Thymic Selection Figure 6.  B7-2 expression is decreased in the thymus of  mice deficient for gp39. (A) Expression of  B7-2-bearing cells in cryostat sections ofwt thymus 
is prominent in medullary regions but undetectable in the cortex or paracortex. (B) The level of  B7-2 expression is decreased in the thymus of gp39-de- 
ficient mice. Images show digital pictures of  the thymus after laser scanning sections stained with B7-2 as described in Materials and Methods. (C) Quan- 
tification of the fluorescence signal is depicted in the histograms. The average fluorescence intensity of B7-2 expression in wt thymus is shown in the 
green bars, and gp39-deficient thymus is shown in the red bars. The histograms represent the overall average fluorescence intensity for all sections scanned 
in a single experiment. A total of 34 sections from each wt and gp39-deficient thymus were analyzed in two separate experiments. 
1385  Foy et al. Table 4.  Induction  of  gp39 on Thymocytes 
gp39 + as % of each thymocyte subset* 
Stimulus*  Total  CD3 +  CD4 +  CD8 +  DP  DN 
None  0. l  -  - 
200 nM PCC  5.2  ND  93.9 
Con A  16.3  54.0  ND 
PMA+ 
ionomycin  25.0  72.0  ND 
cells (9). Whether CD40 signaling directly up-regulates co- 
stimulatory molecule expression on thymic epithelial cells 
or thymic dendritic  cells has not yet been critically tested. 
Data presented in this study show that the genetic deletion 
ofgp39 or the administration ofanti-gp39 to neonatal mice 
(data  not  shown)  significantly  reduces  the  medullary  ex- 
-  -  -  pression  of B7-2.  Unfortunately,  B7-1  expression  in  the 
0.4  5.7  0  thymus was not  detectable in  our hands.  Supportive evi- 
ND  ND  ND  dence for a role  of gp39  in thynfic  expression of B7  also 
comes from studies that have shown that B7 expression in 
ND  ND  ND  the thymus is T  cell dependent (5). 
Evidence that CD28-B7 interactions play a role in nega- 
tive selection comes from in vitro studies (4) showing that 
the induction of apoptosis of DP thymocytes by anti-CD3 
required  simultaneous  engagement  of CD28.  Moreover, 
the observation that the restricted expression of B7 on thy- 
mic medullary cells correlates well with the preferential de- 
letion of self-reactive thymocytes in the medulla is sugges- 
tive  of a  causal  role  for  B7  in  negative  selection  (5). 
Although these studies build a strong circumstantial case for 
B7  playing  a  causal  role  in  negative  selection,  definitive 
proof of a  role  for  B7  negative  selection  has  not  been 
readily obtained. Direct evidence for the lack of CD28 in- 
volvement in  selection  is  provided  by studies  in  CD28- 
deficient  mice  in  which  the  deletion  of  Mlsla-reactive 
VI36-  or  H-2Ek-reactive  V~311-bearing  T  cells  appeared 
unaltered  (36).  In addition,  studies  by Kruisbeek and  co- 
workers (8)  have shown that the administration  of human 
CTLA4-Ig did not alter the deletion of Vf35- or V[36-bear- 
ing thymocytes to Mls in (C57BL/6  ￿  DBA/2)F1  (BDFj) 
mice. The authors did not exclude a role for CD28-B7 in- 
teractions,in  thymocyte death but  concluded  that CD28- 
B7 interactions did not perform a role in thymocyte dele- 
tion.  In addition to these in vivo studies,  several in vitro 
studies do not support the conclusion that costimulation is 
involved in  negative  selection.  Using  an  in  vitro  culture 
system that  included  CD4+CD8 +  (DP)  thymocytes from 
Tg mice expressing the AND TCR, investigators demon- 
strated that B7 was not required to mediate negative selec- 
tion  (3).  However,  results from these  studies  did  confirm 
that an APC-derived costimulatory signal was required for 
negative selection. In a separate study, using an in vitro de- 
letion  assay involving thymocytes expressing the  Tg H-Y 
antigen--specific TCR  cultured with H-Y  + dendritic  cells, 
Teh and co-workers demonstrated that neither CTLA-4 Ig 
nor B7  Ig fusion proteins block negative selection of DP 
thymocytes (6). In this study, the authors suggested that the 
level of B7  expressed on  thymic  epithelial  cells  is  inade- 
quate  to  provide  a  costimulatory  signal  (6).  Given  that 
many factors may contribute  to  the  requirements  for co- 
stimulation in negative selection, the role of B7-1 and B7-2 
in the process of negative selection must be revisited in a 
more comprehensive manner. Finally, the data presented in 
this study do not provide any proof of B7 involvement in 
negative selection; they prove only that gp39-CD40 inter- 
actions are important.  It is possible that gp39-induced  ex- 
pression ofcytokines or costimulatory molecules other than 
B7 is important for the selection process. 
An Essential Role for gp39, the Ligand for CD40, in Thymic Selection 
*Thymocytes  (5 ￿  106/ml) from AND TCR Tg mice (for Ag-induced 
expression) or normal B10.BtL mice (for Con A- or PMA/ionomycin- 
induced expression) were cultured for 12 h in the presence or absence 
of PCC, Con A (5 Izg/ml), or PMA (10 ng/ml) and ionomycin (250 
nM). 
*Thymocytes expressing gp39 were detected flow cytometrically by 
staining with a combination of CD4-PE, CD8-Cy, and biotin anti- 
gp39. A minimum of 10,000 cells were analyzed for each sample. One 
of three representative experiments  is shown. 
in mice in which the administration of anti-gp39 was used 
to block the function of the molecule. While it is clear that 
anti-gp39 can block the binding of CD40 to gp39, it is also 
possible that the antibody may directly transduce signals  to 
the thymocyte via gp39.  It is conceivable that the binding 
of anti-gp39  to activated, gp39-expressing thymocytes in- 
duces a positive signal to rescue them from negative selec- 
tion.  However,  we  have  never documented  any positive 
effects of anti-gp39  on thymocyte or mature T  cell func- 
tions (data not shown). Nonetheless,  one report does indi- 
cate  that gp39  engagement can costimulate the  activation 
of mature T  cells  to anti-CD3  (31).  The fact that genetic 
deletion  of gp39  also  alters  the  selection  of specific V[3- 
bearing  thymocytes  strongly  argues  that  the  absence  of 
gp39  function,  and  not positive signaling via gp39,  alters 
negative  selection.  Finally,  although  CD40  is  the  only 
identified receptor for gp39 to date, our studies do not rule 
out the possibility that gp39 may be mediating negative se- 
lection in the thymus through the interaction with another, 
as yet unidentified,  gp39-binding molecule. 
Based on the arguments presented above, it appears that 
the loss ofgp39 function permits the escape of self-reactive 
thymocytes.  Although  much  of the  literature  examining 
thymocyte selection suggests that TC1k-derived signals alone 
are sufficient to induce death,  there is precedence that ad- 
ditional costimulatory molecules are required for negative 
selection (3,  32,  33).  Because a major function  of gp39  is 
the regulation of costimulatory molecules (23,  24,  34, 35), 
it is reasonable to speculate that gp39 regulates negative se- 
lection via its influence on the expression of costimulatory 
molecules within  the thymic environment.  Triggering via 
CD40 has been shown to up-regulate the expression of co- 
stimulatory  molecules  on  B  cells,  dendritic  cells,  and 
Langerhans  cells  (22-24).  Furthermore,  CD40  has  been 
shown  to  be  functionally  expressed  on  thymic  epithelial 
1386 There  are  many  genetic  loci  that  contribute  to  an  in- 
creased  risk  of autoimmune  disease.  Mutations  in genetic 
loci  that  alter  the  function  of the  costimulatory  "loop" 
identified in this study may alter the effciency with which 
self-reactive  T  cells  are  centrally  deleted  and  may permit 
the  escape of autoreactive  T  cells  to the  periphery.  Based 
on  the  findings  presented,  low-to-moderate-affnity,  self- 
reactive T  cells may most easily escape deletion when this 
costimulatory loop is incapacitated by mutation.  However, 
in the context of the same mutations, high-affinity, self-re- 
active  T  cells  may be  effectively deleted  by a  gp39-inde- 
pendent mechanism.  It would be predicted that hyper-IgM 
patients (who lack functional gp39 [37]) would have a high 
frequency of autoreactive  T  cells  in the  periphery.  While 
this  may be  the  case,  the  absence  of gp39  expression  on 
mature T  cells would most likely limit the ability of those 
T  cells to mediate autoimmune disease  (38).  On the other 
hand,  if there were mutations  that interfered with  CD40- 
dependent  deletion  within  the  thymus,  then  functional-, 
low-, or moderate-affnity autoreactive T  cells may escape 
selection. In addition to genetic mutations, xenobiotics that 
alter this loop may also be autoimmunogenic. For example, 
it has been shown that cyclosporine A  (CsA), an inhibitor 
of gp39 expression  (12),  can block negative  selection  (39, 
40). The fact that negative selection is blocked by CsA may 
be the basis for the increased incidence of autoimmune dis- 
ease in CsA-treated patients  (41-43).  Support for this  hy- 
pothesis is currently being sought through studies in strains 
of mice that are prone to the development of autoimmune 
disease. 
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